Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (8)
Leukemia (3)
Scientific Reports (2)
Molecular Psychiatry (1)
Neuropsychopharmacology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (17)
Correspondence (2)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biological techniques
Cancer
Chemical biology
Computational biology and bioinformatics
Diseases
Gastroenterology
Immunology
Medical research
Microbiology
Neuroscience
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–19 of 19 results

Advanced filters: Author: G Vreugdenhil Clear advanced filters

De novo sequencing of glycans by ion mobility-mass spectrometry using a self-expanding database

This study introduces an ion mobility–mass spectrometry method for de novo glycan structure identification, using a self-expanding database that reduces reliance on synthetic reference standards.

Javier Sastre Toraño
Julia C. C. Vreugdenhil
Geert-Jan Boons
ResearchOpen Access13 Dec 2025
Nature Communications

Volume: 17, P: 1-14
Glycine receptor β–subunit gene mutation in spastic mouse associated with LINE–1 element insertion

Stephen F. Kingsmore
Bruno Giros
Michael F. Seldin
Research01 Jun 1994
Nature Genetics

Volume: 7, P: 136-142
Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis

M. Bloem
M. M. de Meza
M. W. J. M. Wouters
Research15 Apr 2025
British Journal of Cancer

Volume: 132, P: 1124-1130
Progress towards non-invasive diagnosis and follow-up of celiac disease in children; a prospective multicentre study to the usefulness of plasma I-FABP

M. P. M. Adriaanse
A. Mubarak
J. B. G. Wijnands
ResearchOpen Access17 Aug 2017
Scientific Reports

Volume: 7, P: 1-10
Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia

A Glasmacher
E Molitor
T Sauerbruch
Research02 Sept 1998
Leukemia

Volume: 12, P: 1338-1343
Rechallenge of ipilimumab and nivolumab in advanced melanoma patients after previous ipilimumab-based therapy

E. J. van Dijk
H. H. Nienhuis
K. P. M. Suijkerbuijk
Research29 Apr 2025
British Journal of Cancer

Volume: 133, P: 66-75
Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanoma

Laurens S. Ter Maat
Rob A. J. De Mooij
Mitko Veta
ResearchOpen Access30 Dec 2024
Scientific Reports

Volume: 14, P: 1-11
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon α for metastatic melanoma: a multicentre phase II study

CJA Punt
CML van Herpen
PHM de Mulder
Research01 Jul 1997
British Journal of Cancer

Volume: 76, P: 266-269
Effects of Peroxisome Proliferator-Activated Receptor Gamma Agonists on Brain Glucose and Glutamate Transporters after Stress in Rats

Borja García-Bueno
Javier R Caso
Juan C Leza
Research22 Nov 2006
Neuropsychopharmacology

Volume: 32, P: 1251-1260
Chronic corticosterone-mediated dysregulation of microRNA network in prefrontal cortex of rats: relevance to depression pathophysiology

Y Dwivedi
B Roy
N R Smalheiser
ResearchOpen Access17 Nov 2015
Translational Psychiatry

Volume: 5, P: e682
Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients

S Houterman
M L G Janssen-Heijnen
J W W Coebergh
ResearchOpen Access25 May 2004
British Journal of Cancer

Volume: 90, P: 2332-2337
Knockdown of the glucocorticoid receptor alters functional integration of newborn neurons in the adult hippocampus and impairs fear-motivated behavior

C P Fitzsimons
L W A van Hooijdonk
E Vreugdenhil
Research28 Aug 2012
Molecular Psychiatry

Volume: 18, P: 993-1005
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses

Rinke Bos
Lucy Rutten
Hanneke Schuitemaker
ResearchOpen Access28 Sept 2020
npj Vaccines

Volume: 5, P: 1-11
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial

S Keating
S Suciu
R Willemze
Research03 Jan 2003
Leukemia

Volume: 17, P: 60-67
Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study

Monique K. van der Kooij
Arjen Joosse
Ellen Kapiteijn
Correspondence23 Dec 2022
British Journal of Cancer

Volume: 128, P: 707-710
Long-term follow-up after cancer rehabilitation using high-intensity resistance training: persistent improvement of physical performance and quality of life

I C De Backer
G Vreugdenhil
G Schep
ResearchOpen Access24 Jun 2008
British Journal of Cancer

Volume: 99, P: 30-36
Comment on: ‘Subgroup effects in a randomized trial of different types and doses of exercise during breast cancer chemotherapy’

A J M Beijers
A L J Verhulst
G Vreugdenhil
CorrespondenceOpen Access04 Dec 2014
British Journal of Cancer

Volume: 112, P: 1835
Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy

L Fallowfield
D Gagnon
M Freund
ResearchOpen Access26 Nov 2002
British Journal of Cancer

Volume: 87, P: 1341-1353
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)

M Oosterveld
S Suciu
T de Witte
Research15 May 2003
Leukemia

Volume: 17, P: 859-868